Johnson & Johnson MedTech published a retrospective observational study comparing the DePuy Synthes ACTIS Hip System to the Accolade II Femoral Hip System to show positive patient outcomes and reduced hospital costs.
Published
Signal category
Research & Knowledge
Quote
“I am excited to share some new research from a retrospective observational study that shows that the DePuy Synthes ACTIS™ Hip System has a positive impact on patient outcomes and reduces hospital costs when compared with the Accolade® II Femoral Hip System!”
— Lawrence "J.R." Manuel|Johnson & Johnson MedTech team
Company
- Industry
- Hospitals and Health Care
- Location
- New Brunswick, US
- Company size
- 38,074 employees
At Johnson & Johnson MedTech, we are working to solve the world’s most pressing healthcare challenges through innovations at the intersection of biology and technology. With deep expertise in surgery, orthopaedics, cardiovascular, and vision, we design healthcare solutions that are smarter, less invasive and more personalized. We are developing the next generation of med tech solutions to tackle the most pervasive and complex health challenges for people around the world. Community Guidelines: http://www.jnj.com/social-media-community-guidelines